Tech Sell-Off
-
UBS Reports Robust Earnings, Novo Nordisk U.S. Shares Plunge on Growth Slowdown
UBS reported a strong earnings surge, exceeding expectations with a 56% profit jump and announcing a significant share buyback. In contrast, Novo Nordisk faces headwinds, warning of slower growth due to pricing pressures and increased competition, despite new product developments. Broader markets experienced a tech sell-off, impacting software and private credit sectors, with AI disruption concerns weighing on valuations. Meanwhile, a government shutdown was averted, and key developments include Nvidia-OpenAI partnership reassurances, Elon Musk’s empire consolidation, a Fed leadership transition, and gold’s continued ascent.
